Science & academia

This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.

DNA, for article on artificial DNA cancer

In a world first, Japenese scientists use artificial DNA to kill cancer cells

By / / Good News For Humankind

Artificial DNA that turns cancer’s own biology against itself marks a genuine conceptual leap in oncology. Japanese researchers at the University of Tokyo engineered synthetic molecules that lie dormant until they detect a chemical cancer cells overproduce — then restructure themselves into a signal the immune system reads as a threat, destroying the tumor from within. Early tests spanned multiple cancer types, suggesting broad potential. This kind of precision — working with the body’s existing defenses rather than overwhelming them — is exactly the direction cancer medicine has been reaching toward, and this research moves that goal meaningfully closer.

Fiery glowing atomic nucleus abstract background, for article on fusion net energy gain

American fusion scientists claim net energy gain, in potentially huge renewables breakthrough

By / / Good News For Humankind

Fusion energy just cleared a barrier scientists have been chasing since the 1950s — producing more energy from a reaction than was needed to trigger it. Researchers at Lawrence Livermore National Laboratory achieved this by blasting tiny hydrogen fuel capsules with lasers until they released roughly 20 percent more energy than the lasers delivered. The result doesn’t mean fusion power plants are imminent; enormous engineering challenges remain between this laboratory milestone and a working grid. But it does confirm that fusion’s central promise is physically real — and that gives scientists, investors, and policymakers something genuinely new to build on.

Brain model, for article on glioblastoma vaccine

Vaccine prolongs life of patients with aggressive brain cancer in new trial

By / / Good News For Humankind

Glioblastoma patients now have the most promising new treatment in nearly three decades, after a personalised vaccine more than doubled five-year survival rates in a large international trial. The vaccine works by extracting proteins from a patient’s own tumour and combining them with their white blood cells, training the immune system to recognise and destroy the cancer — with benefits seen even among those traditionally considered hardest to treat. If regulators approve it, this could signal a new era of personalised immunotherapy for cancers that have long resisted every available option.

Rolls-Royce & easyJet hydrogen engine, for article on hydrogen jet engine

World’s first test run of a hydrogen jet engine proves a success

By / / Good News For Humankind

Hydrogen-powered flight moved from theory to reality when Rolls-Royce and easyJet successfully ran a modern jet engine on green hydrogen produced entirely from wind and tidal energy. Unlike battery-electric approaches, hydrogen burns clean — releasing water vapor instead of carbon dioxide — and this test proved a real engine can handle it. Aviation has been one of the hardest sectors to decarbonize, so a confirmed proof of concept opens a genuine path forward. Every major breakthrough in flight history started exactly here: on the ground, with an engine, and a question that finally got answered.

Human eye up close, for article on Gennaris bionic vision system

Monash University develops world’s first bionic eye to fully restore vision in blind people

By / / Good News For Humankind

Gennaris, a bionic vision system from Monash University, could open a path to sight for people whose blindness stems from optic nerve damage — a group that most existing visual aids simply cannot help. The device bypasses the eye entirely, sending signals from a camera headset directly to tiles implanted in the brain, which then create perceivable points of light. Sheep trials confirmed the implants are safe and stable in brain tissue, and human trials are now being planned. If it succeeds, the underlying technology could eventually be adapted to assist people living with paralysis too.